Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Central sensitization is a form of maladaptive neuroplasticity underlying many chronic pain disorders, including neuropathic pain, fibromyalgia, whiplash, headache, chronic pelvic pain syndrome and some forms of osteoarthritis, low back pain, epicondylitis, shoulder pain and cancer pain. Brain-derived neurotrophic factor (BDNF) is a driving force behind neuroplasticity, and it is therefore crucial for neural maintenance and repair. However, BDNF also contributes to sensitization of pain pathways, making it an interesting novel therapeutic target. AREAS COVERED: An overview of BDNF's sensitizing capacity at every level of the pain pathways is presented, including the peripheral nociceptors, dorsal root ganglia, spinal dorsal horn neurons, and brain descending inhibitory and facilitatory pathways. This is followed by the presentation of several potential therapeutic options, ranging from indirect influencing of BDNF levels (using exercise therapy, anti-inflammatory drugs, melatonin, repetitive transcranial magnetic stimulation) to more specific targeting of BDNF's receptors and signaling pathways (blocking the proteinase-activated receptors 2-NK-κβ signaling pathway, administration of phencyclidine for antagonizing NMDA receptors, or blockade of the adenosine A2A receptor). EXPERT OPINION: This section focuses on combining pharmacotherapy with multimodal rehabilitation for balancing the deleterious and therapeutic effects of BNDF treatment in chronic pain patients, as well as accounting for the complex and biopsychosocial nature of chronic pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Central sensitization: implications for the diagnosis and treatment of pain
Woolf, C. J. (2011) · Pain · doi:10.1016/j.pain.2010.09.030 · Cited by 4,771 · cited 1×
“CS is a form of neuroplasticity that has been defined as ‘an amplification of neural signaling within the CNS eliciting pain hypersensitivity’ [2] or ‘an augmentation”
BackgroundMillan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Lefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119
Neurotrophin regulation of neural circuit development and function
Park, H., & Poo, M.-M. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3379 · Cited by 2,060 · cited 1×
“Also, BDNF may have positive effects on cognition [35,36], serves as a key regulator of neural circuit development and function [37], and is capable of mediating many activity-dependent processes, including neuronal differentiation and growth, synapse formation and plasticity [37].”
BackgroundBDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
Coull, J. A. M., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel, C., Salter, M. W., & De Koninck, Y. (2005) · Nature · doi:10.1038/nature04223 · Cited by 1,965 · cited 2×
“Some groups found that intrathecal injection of BDNF produces tactile allodynia in normal mice [50,56-58], while others reported that spinal application of BDNF alleviates neuropathic pain [59-61].”
BackgroundBDNF and synaptic plasticity, cognitive function, and dysfunction
Lu, B., Nagappan, G., & Lu, Y. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_9 · Cited by 1,043 · cited 2×
“Indeed, BDNF is an important facilitator of LTP especially in regions involved in learning and memory like the hippocampus [74,75].”
BackgroundKnaepen, K., Goekint, M., Heyman, E. M., & Meeusen, R. (2010) · Sports Medicine · doi:10.2165/11534530-000000000-00000 · Cited by 882
Self-citationGDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration
Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.004 · Cited by 820 · cited 2×
“Consequently, the protein inhibitor must be infused directly, secreted from implanted protein-secreting cells or actively transported across the blood--brain barrier [129].”
BackgroundYarnitsky, D. (2010) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32833c348b · Cited by 745 · cited 1×
“The dysfunctions of the CNS as seen in CS include altered sensory processing [21], malfunctioning of descending anti-nociceptive mechanisms [22,23], increased activity of pain facilitatory pathways, enhanced temporal summation of second pain or windup [24,25], and more pronounced and distinct brain activity during pai…”
BackgroundEndurance training enhances BDNF release from the human brain
Seifert, T., Brassard, P., Wissenberg, M., Rasmussen, P., Nordby, P., Stallknecht, B., Adser, H., Jakobsen, A. H., Pilegaard, H., Nielsen, H. B., et al. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00525.2009 · Cited by 502
Murakami, S., Imbe, H., Morikawa, Y., Kubo, C., & Senba, E. (2005) · Neuroscience Research · doi:10.1016/j.neures.2005.06.008 · Cited by 398
Coelho, F. G. D. M., Gobbi, S., Andreatto, C. A. A., Corazza, D. I., Pedroso, R. V., & Santos-Galduróz, R. F. (2013) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2012.06.003 · Cited by 327 · cited 2×
“When administered together with pharmacotherapy for temporally shutting down BNDF-release in (certain parts of) the pain pathways, physical activity promotion and/or exercise therapy may allow for the BDNF-release [114,115] required for neural health.”
BackgroundAbnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions
Staud, R. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.41 · Cited by 290 · cited 1×
“3 Sensitizing role of BDNF at the brain level Malfunctioning of brain-orchestrated, descending antinociceptive mechanisms is often an important feature of CS pain [63-65].”
BackgroundTak, L. M., Cleare, A. J., Ormel, J., Manoharan, A., Kok, I. C., Wessely, S., & Rosmalen, J. G. M. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.02.002 · Cited by 230 · cited 1×
“Yet patients with CS pain often have a blunted cortisol response to stress [95-97], questioning whether stress is accompanied by decreased BDNF levels.”
BackgroundGuo, W., Robbins, M. T., Wei, F., Zou, S., Dubner, R., & Ren, K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3686-05.2006 · Cited by 192 · cited 1×
“In addition, BDNF-containing neurons in the periaqueductal gray, one of the key brain centers for orchestrating descending antinociception, project to and release BDNF in the rostral ventromedial medulla, which in turn facilitates nociception in an NMDA receptor-dependent manner [68].”
BackgroundBarrientos, R. M., Sprunger, D. B., Campeau, S., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.06.009 · Cited by 192 · cited 1×
“, infusion of IL-1 into the hippocampus) decreases its capacity of BDNF transcription [85].”
BackgroundSchwertner, A., Conceição dos Santos, C. C., Costa, G. D., Deitos, A., de Souza, A., de Souza, I. C. C., Torres, I. L. S., da Cunha Filho, J. S. L., & Caumo, W. (2013) · Pain · doi:10.1016/j.pain.2013.02.025 · Cited by 155
Ferrer, I., Krupinski, J., Goutan, E., Martí, E., Ambrosio, S., & Arenas, E. (2001) · Acta Neuropathologica · doi:10.1007/s004010000268 · Cited by 153 · cited 1×
“This notion is supported by animal findings revealing anti-inflammatory action ofBDNFon the brain [33] and decreased cortical cell death after its administration [34].”
ResultForti, L. N., Njemini, R., Beyer, I., Eelbode, E., Meeusen, R., Mets, T., & Bautmans, I. (2014) · AGE · doi:10.1007/s11357-014-9704-6 · Cited by 67 · cited 1×
“Further to the possible role of exercise therapy for influencing BDNF levels, strengthening exercise rather than aerobic exercise has been shown to increase peripheral BDNF levels in depressed patients [114], and aerobic [115] but not strengthening exercise [116] increased peripheral BDNF levels in an elderly populati…”
BackgroundSelf-citation
Cited by
Tumor microenvironment: barrier or opportunity towards effective cancer therapy
Tiwari, A., Trivedi, R., & Lin, S.-Y. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00866-3 · Cited by 377
Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies
Cervantes-Villagrana, R. D., Albores-García, D., Cervantes-Villagrana, A. R., & García-Acevez, S. J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0205-z · Cited by 290
Neurotrophins and Neuropathic Pain: Role in Pathobiology
Khan, N., & Smith, M. (2015) · Molecules · doi:10.3390/molecules200610657 · Cited by 200
“NTs contribute to the pathogenesis of neuropathic pain as they have key roles in the complex mechanisms that underpin peripheral and central sensitisation [15–17].”
BackgroundKey role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain
Yang, C., Fang, X., Zhan, G., Huang, N., Li, S., Bi, J., Jiang, R., Yang, L., Miao, L., Zhu, B., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0379-8 · Cited by 176
Brain-derived neurotrophic factor derived from sensory neurons plays a critical role in chronic pain
Sikandar, S., Minett, M. S., Millet, Q., Santana-Varela, S., Lau, J., Wood, J. N., & Zhao, J. (2018) · Brain · doi:10.1093/brain/awy009 · Cited by 168
“These findings sup- port the therapeutic potential of modulating BDNF for chronic pain syndromes (Nijs et al., 2015).”
Background
Metadata
- Authors
- Nijs, J., Meeus, M., Versijpt, J., Moens, M., Bos, I., Knaepen, K., & Meeusen, R.
- Venue
- Expert Opinion on Therapeutic Targets
- Publisher
- Informa UK Limited
- Published
- 2014-12-18
- Volume
- 19
- Issue
- 4
- Pages
- 565-576
- ISSN
- 1472-8222 (ISSN-L)
- 1744-7631
- OpenAlex
- W2055755492
- Cited by
- 180
- References
- 19
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.